Key terms
About VCEL
Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest VCEL news
Apr 15
7:37am ET
Vericel price target raised to $56 from $53 at BTIG
Mar 26
8:50am ET
Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Inotiv (NOTV) and Vericel (VCEL)
Mar 24
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)
Mar 18
4:24pm ET
Vericel management to meet with Truist
Mar 01
8:14am ET
Vericel price target raised to $54 from $51 at Truist
Mar 01
7:53am ET
Vericel price target raised to $47.40 from $42.40 at Ladenburg
Mar 01
7:40am ET
Analysts Conflicted on These Healthcare Names: Vericel (VCEL), Tenet Healthcare (THC) and Veeva Systems (VEEV)
Mar 01
6:26am ET
Buy Rating Affirmed for Vericel on Strong Financials and Growth Prospects
Mar 01
6:24am ET
Vericel price target raised to $53 from $46 at H.C. Wainwright
Feb 29
8:02am ET
Vericel sees 2024 revenue $237M-$241M, consensus $240.82M
Feb 29
7:59am ET
Vericel reports Q4 EPS 26c, consensus 17c
Feb 22
5:25am ET
BTIG Keeps Their Buy Rating on Vericel (VCEL)
Feb 20
7:32am ET
Vericel price target raised to $53 from $49 at BTIG
Feb 20
6:15am ET
BTIG Remains a Buy on Vericel (VCEL)
Jan 25
9:49am ET
Tesla, Boeing downgraded: Wall Street’s top analyst calls
Jan 25
9:49am ET
Tesla, Boeing downgraded: Wall Street’s top analyst calls
Jan 25
6:06am ET
Vericel upgraded to Buy from Hold at Truist
Jan 19
7:29am ET
Vericel price target raised to $42.40 from $40 at Ladenburg
No recent press releases are available for VCEL
VCEL Financials
Key terms
Ad Feedback
VCEL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
VCEL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range